ย API China 2026 Highlights
Jurie Hwang, Director of Public & International Affairs at the Korea Biotechnology…
UAE Among First Globally to Approve New Obesity and Hypertension Treatments
The United Arab Emirates is strengthening its global leadership in healthcare innovation…
FDA Approves Merckโs NUMELVI for Allergic Dermatitis in Dogs
Merck Animal Health has received FDA approval for NUMELVIโข (atinvicitinib), a next-generation…
Visitor Insight Highlights | API Chongqing Expo 2025
Visitor Insight Highlights from API Chongqing Expo 2025 showcase industry perspectives on…
CPHI & BIO Middle East 2026 Rescheduled to December in Riyadh
CPHI & BIO Middle East 2026 has been rescheduled to December in…
Bayerโs Kerendia Gains EU Approval for Expanded Use in Heart Failure Treatment
Bayer receives European Commission approval to expand the use of Kerendia (finerenone)…
DUPHAT announces new dates for 2026 edition
The organisers of DUPHAT have confirmed the new dates for the 2026…
โAmbition Must Be Aligned with Responsibility in the Healthcare Systemโ
The Middle Eastโs position as a global healthcare leader continues to strengthen,…
FDA Grants Breakthrough Therapy Designation to Novartisโ Ianalumab for Sjรถgrenโs Disease
The FDA has granted Breakthrough Therapy designation to Novartisโ ianalumab for Sjรถgrenโs…
NVIDIA and Lilly Launch AI Co-Innovation Lab for Next-Generation Drug Discovery
NVIDIA and Lilly launch a $1 billion AI co-innovation lab in San…